Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiying Han

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Brain Research Bulletin|July 15, 2021
Long non-coding RNA MIAT impairs neurological function in ischemic stroke via up-regulating microRNA-874-3p-targeted IL1BShuai Zhang, Yue Zhang, Na Wang, et al.
Molecular Pharmaceutics|October 20, 2018
The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple MyelomaJie Gu, Sha Song, Huiying Han, et al.
Molecular Pharmaceutics|July 27, 2018
Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple MyelomaJixiang Shi, Sha Song, Huiying Han, et al.
Pest Management Science|March 6, 2026
The role of Ca<sup>2+</sup>-calcineurin signaling pathway on the antifungal activity of Murrayone against Botrytis cinereaYao Yu, Wanyun Zhu, Huiying Han, et al.
Science Advances|April 27, 2022
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expressionAustin G Holmes, J Brandon Parker, Vinay Sagar, et al.
Oncogene|June 14, 2018
Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesisBingzong Li, Hongxia Xu, Huiying Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2019
Exosome-Transmitted <i>PSMA3</i> and <i>PSMA3-AS1</i> Promote Proteasome Inhibitor Resistance in Multiple MyelomaHongxia Xu, Huiying Han, Sha Song, et al.
Stem Cells (Dayton, Ohio)|October 25, 2018
HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with Its Natural Antisense Transcript lncHOXC-AS3Bingzong Li, Huiying Han, Sha Song, et al.
Cancer Research|April 11, 2022
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate CancerYara Rodríguez, Kenji Unno, Mihai I Truica, et al.
Cell Death & Disease|October 24, 2019
EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cellsVinay Sagar, Rajita Vatapalli, Barbara Lysy, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Brain Research Bulletin|July 15, 2021
Long non-coding RNA MIAT impairs neurological function in ischemic stroke via up-regulating microRNA-874-3p-targeted IL1BShuai Zhang, Yue Zhang, Na Wang, et al.
Molecular Pharmaceutics|October 20, 2018
The BET Bromodomain Inhibitor OTX015 Synergizes with Targeted Agents in Multiple MyelomaJie Gu, Sha Song, Huiying Han, et al.
Molecular Pharmaceutics|July 27, 2018
Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple MyelomaJixiang Shi, Sha Song, Huiying Han, et al.
Pest Management Science|March 6, 2026
The role of Ca<sup>2+</sup>-calcineurin signaling pathway on the antifungal activity of Murrayone against Botrytis cinereaYao Yu, Wanyun Zhu, Huiying Han, et al.
Science Advances|April 27, 2022
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expressionAustin G Holmes, J Brandon Parker, Vinay Sagar, et al.
Oncogene|June 14, 2018
Exosome-mediated transfer of lncRUNX2-AS1 from multiple myeloma cells to MSCs contributes to osteogenesisBingzong Li, Hongxia Xu, Huiying Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2019
Exosome-Transmitted <i>PSMA3</i> and <i>PSMA3-AS1</i> Promote Proteasome Inhibitor Resistance in Multiple MyelomaHongxia Xu, Huiying Han, Sha Song, et al.
Stem Cells (Dayton, Ohio)|October 25, 2018
HOXC10 Regulates Osteogenesis of Mesenchymal Stromal Cells Through Interaction with Its Natural Antisense Transcript lncHOXC-AS3Bingzong Li, Huiying Han, Sha Song, et al.
Cancer Research|April 11, 2022
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate CancerYara Rodríguez, Kenji Unno, Mihai I Truica, et al.
Cell Death & Disease|October 24, 2019
EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cellsVinay Sagar, Rajita Vatapalli, Barbara Lysy, et al.
Pageof 3